The observation that four of six human NSCLC cell lines harbouring EGFR mutations were positive for EGFR amplification, whereas none of the ten cell lines negative for EGFR mutations manifested EGFR amplification, supported a close association between these two genetic alterations [36]. Here, EGFR is linked to non-small cell lung carcinoma.